J. Bloss

A phase II trial of arzoxifene, a selective estrogen response modulator, in patients with recurrent or advanced endometrial cancer

D. Scott McMeekin, Alan N. Gordon, Jeffrey M. Fowler et al. · Gynecologic Oncology · 2003 · 81 citations

Advanced Endometrial Cancer, Oncology, Phase Ii Trial +7

A randomized phase III trial of gemcitabine (G) in combination with carboplatin (C) or paclitaxel (P) versus paclitaxel plus carboplatin in advanced (Stage IIIB, IV) non-small cell lung cancer (NSCLC): Update of the Alpha Oncology trial (A1–99002L)

Joseph Treat, Chandra P. Belani, Martin J. Edelman et al. · Journal of Clinical Oncology · 2005 · 53 citations

Advanced Nsclc, Therapeutic Drug Monitoring, Oncology +14

Ophthalmomyiasis interna anterior associated with Cuterebra spp in a cat

P. Elliott Miller, J. Bloss, Phillip Pellitteri · Journal of the American Veterinary Medical Association · 2000 · 39 citations

Ocular Disease, Ophthalmology, Experimental Ophthalmology +13

Serum CA125 regression in epithelial ovarian cancer: Correlation with reassessment findings and survival

Richard E. Buller, Michael L. Berman, J. Bloss et al. · Gynecologic Oncology · 1992 · 35 citations

Epithelial Ovarian Cancer, Medicine, Pathology +9

Extraovarian peritoneal serous papillary carcinoma: A case‐control retrospective comparison to papillary adenocarcinoma of the ovary

J. Bloss, S Y Liao, R.E. Buller et al. · International Journal of Gynecology & Obstetrics · 1994 · 23 citations

Surgical Oncology, Tumoral Pathology, Gynecological Surgery +7